Avantor, Inc. (AVTR) is a Technology stock trading at $14.26 (as of 2026-08-20), with a market capitalization of $9.73B. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.
Avantor provides products and services for biopharma, healthcare, education, and government customers, including lab materials and consumables (such as purity chemicals and reagents) plus lab supplies, process chromatography resins and columns, and clinical trial kits, and it makes money by selling these products and services to its customers.
Profitability is driven by how much customers spend on lab and bioscience consumables and related offerings, with the company’s revenue mix split across Laboratory Solutions and Bioscience Production.
| Lab Sol | $1.1B |
| Bio Prod | $0.6B |
Business quality (Weak): Segment split and KPI visibility are limited to the provided candidate labels and values, so the shown segment breakdown is an approximation based on available data.
| Price | $14.26 |
| Market Cap | $9.73B |
| EV / EBITDA | 109.3 |
| Price / Book | 1.74 |
| Price / Sales | 1.49 |
| FCF Yield | 4.5% |
| DCF Value (model) | $13.32 |
| DCF Upside vs Price | -6.6% |
| Revenue (TTM) | $6.55B |
| Net Margin | -8.1% |
| Revenue Growth (YoY) | 0.0% |
| EPS Growth (YoY) | -33.3% |
| FCF Growth (YoY) | -69.0% |
| Altman Z-Score | 1.73 (distress) |
| Piotroski F-Score | 4/9 (moderate) |
| Sector P/E (Technology) | 33.9 |
| Industry P/E (Measuring & Control Equipment) | 51.8 |
| Top Institutional Holder | Dodge & Cox ($938.04M) |
| Institutional Holders Tracked | 10 |
| Congressional Trades (recent) | 9 |
| Sector | Technology |
| Industry | Measuring & Control Equipment |
| CEO | Emmanuel Ligner |
| Employees | 13,500 |
| Country | US |
| IPO Date | 2019-05-17 |
Data as of 2026-08-20.
Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.